Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

  • This share is currently suspended. It was suspended at a price of 130.00
  • There is currently no data for DLAR

Trading Statement

13 Apr 2021 07:00

RNS Number : 2105V
De La Rue PLC
13 April 2021
 

13 April 2021

DE LA RUE PLC

TRADING UPDATE

De La Rue plc (LSE: DLAR) ("De La Rue" or the "Company") today announces a trading update for financial year 2020/21, which ended 27 March 2021.

 

As a result of continued positive trading, the Board expects Adjusted Operating Profit for the financial year 2020/21 to be around the top end of the £36 million to £37 million range previously indicated in the Company's trading update of 28 January 2021.

End of year Net Debt was approximately £53 million, which is lower than market expectations(1) by approximately £21 million. This is mainly due to lower capital expenditure during the year, consistent with adjustments made to the timing of capital spend as the Turnaround Plan has evolved. Total aggregate 3-year cash investment for the Turnaround Plan remains unchanged.

Due to the positive outcome of the financial year, the Company has repaid all the money received from HM Government's Coronavirus Job Retention Scheme. Furlough payments received under this scheme totalled approximately £0.4m.

In the results for financial year 2020/21, the Company will record non-cash exceptional asset impairment and accelerated depreciation charges of approximately £13 million on historic assets, as a result of the closure of the Gateshead banknote printing operations in December 2020. Of this, approximately £12m was recorded in the second half of the year following finalisation of the detailed plans for which assets currently are expected to have any ongoing use within the group.

De La Rue expects to announce its results for the full year ended 27 March 2021 on 26 May 2021.

De La Rue plc's LEI code is 213800DH741LZWIJXP78.

(1). Market expectations are based on the average of published notes from Investec and Numis Securities.

Enquiries:

 

De La Rue plc

 

+44 (0) 7387 122645

Clive Vacher

 

Chief Executive Officer

Rob Harding

 

Chief Financial Officer

Matthew Rose

 

Director of Tax, Treasury and Investor Relations

 

Brunswick Group LLP +44 (0)207 404 5959

Stuart Donnelly/Ed Brown

 

 

Cautionary note regarding forward-looking statements

 

This announcement includes statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "anticipates", "expects", "intends", "plans", "may", "will", "could", "shall", "risk", "aims", "predicts", "continues", "assumes", "positioned" or "should" or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this announcement and include statements regarding the intentions, beliefs or current expectations of the directors, De La Rue or the Group concerning, amongst other things, the results of operations, financial condition, liquidity, prospects, growth and strategies of De La Rue and the industry in which it operates.

By their nature, forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors because they relate to events and depend on circumstances that will occur in the future whether or not outside the control of the Company. Past performance cannot be relied upon as a guide to future performance and should not be taken as a representation or assurance that trends or activities underlying past performance will continue in the future. Accordingly, investors or potential investors should not place undue reliance on these forward-looking statements. The Group's actual results of operations, financial condition, liquidity and the development of the industry in which it operates may differ materially from the impression created by the forward-looking statements contained in this announcement. In addition, even if the results of operations, financial condition and liquidity of the Group and the development of the industry in which it operates, are consistent with the forward-looking statements contained in this announcement, those results or developments may not be indicative of results or developments in subsequent periods.

Other than in accordance with its legal or regulatory obligations, De La Rue does not undertake any obligation to update these forward-looking statements, which speak only as at the date of this announcement, and will not publicly release any revisions that may be made to these forward-looking statements, which may result from events or circumstances arising after the date of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTITMRTMTBBBFB
Date   Source Headline
17th Jan 20173:15 pmRNSHolding(s) in Company
4th Jan 20172:40 pmRNSDirector/PDMR Shareholding
3rd Jan 20178:43 amRNSBlock Listing Six Monthly Return
3rd Jan 20178:36 amRNSTotal Voting Rights
20th Dec 20169:13 amRNSAdditional Listing
19th Dec 20165:43 pmRNSDirector/PDMR Shareholding
12th Dec 20163:46 pmRNSAdditional Listing
12th Dec 20163:00 pmRNSDe La Rue to aquire DuPont Authentication
30th Nov 20164:22 pmRNSTotal Voting Rights
23rd Nov 20164:07 pmRNSDirector/PDMR Shareholding
22nd Nov 20167:00 amRNSHalf Year Results for 6 months ended 24.09.2016
9th Nov 20165:21 pmRNSHolding(s) in Company
7th Nov 20162:35 pmRNSNotice of Half Year Results
31st Oct 20164:18 pmRNSTotal Voting Rights
11th Oct 20162:03 pmRNSHolding(s) in Company
10th Oct 20166:21 pmRNSHolding(s) in Company
30th Sep 20164:11 pmRNSTotal Voting Rights
26th Sep 20169:01 amRNSNotice of Investor Day
1st Sep 20168:39 amRNSTotal Voting Rights
18th Aug 201610:57 amRNSCreation of Kenya Joint Venture
1st Aug 20169:55 amRNSTotal Voting Rights
29th Jul 20168:36 amRNSAdditional Listing
27th Jul 20163:34 pmRNSDirector/PDMR Shareholding
21st Jul 20164:46 pmRNSResult of AGM
21st Jul 20169:14 amRNSAGM Statement
20th Jul 20169:45 amRNSHolding(s) in Company
13th Jul 20165:16 pmRNSDirector/PDMR Shareholding
7th Jul 201612:34 pmRNSAdditional Listing
1st Jul 20161:42 pmRNSAgreement on Actuarial Pension Valuation
30th Jun 20162:10 pmRNSTotal Voting Rights
30th Jun 20162:07 pmRNSBlock Listing Six Monthly Return
27th Jun 20164:05 pmRNSDirector/PDMR Shareholding
17th Jun 20164:44 pmRNSAnnual Financial Report - Replacement
17th Jun 20163:36 pmRNSAnnual Financial Report
8th Jun 20167:00 amRNSDirectorate Change
7th Jun 20166:16 pmRNSDirector/PDMR Shareholding
6th Jun 20168:22 amRNSAdditional Listing
31st May 20164:50 pmRNSTotal Voting Rights
24th May 20167:00 amRNSFull Year Results Ended 26 March 2016
23rd May 20167:00 amRNSSale of Cash Processing Solutions Limited
10th May 20168:58 amRNSNotice of Results
3rd May 20169:04 amRNSTotal Voting Rights
20th Apr 20167:00 amRNSAdoption of Financial Reporting Standard (FRS) 102
13th Apr 20167:00 amRNSTrading Update
31st Mar 20165:58 pmRNSTotal Voting Rights
31st Mar 20165:54 pmRNSHolding(s) in Company
30th Mar 20165:20 pmRNSHolding(s) in Company
15th Mar 20164:49 pmRNSDirector/PDMR Shareholding
10th Mar 20164:29 pmRNSHolding(s) in Company
29th Feb 20162:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.